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Abstract
Objective
To investigate whether pain-related fears are mediators for reducing disability and pain in
patients with Complex Regional Pain Syndrome type 1 when treating with Pain Exposure
Physical Therapy.
Design
An explorative secondary analysis of a randomised controlled trial.
Participants
Fifty-six patients with Complex Regional Pain Syndrome type 1.
Interventions
The experimental group received Pain Exposure Physical Therapy in a maximum of five
treatment sessions; the control group received conventional treatment following the Dutch
multidisciplinary guideline.
Outcomemeasures
Levels of disability, pain, and pain-related fears (fear-avoidance beliefs, pain catastrophiz-
ing, and kinesiophobia) were measured at baseline and after 3, 6, and 9 months follow-up.
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Results
The experimental group had a significantly larger decrease in disability of 7.77 points (95%
CI 1.09 to 14.45) and in pain of 1.83 points (95% CI 0.44 to 3.23) over nine months than the
control group. The potential mediators pain-related fears decreased significantly in both
groups, but there were no significant differences between groups, which indicated that
there was no mediation.
Conclusion
The reduction of pain-related fears was comparable in both groups. We found no indication
that pain-related fears mediate the larger reduction of disability and pain in patients with
Complex Regional Pain Syndrome type 1 treated with Pain Exposure Physical Therapy
compared to conventional treatment.
Trial registration
International Clinical Trials Registry NCT00817128
Introduction
Complex Regional Pain Syndrome type 1 (CRPS-1) is a debilitating condition that develops
spontaneously or after physical injury, and is characterized by pain and sensory, autonomic,
motor, and/or trophic changes [1]. The exact cause of CRPS-1 is still not fully understood, but
various pathophysiologic pathways have been identified that contribute to the heterogeneous
clinical presentation of the disorder [2].
Aberrant neurogenic inflammation and vasomotor dysfunction cause increased tempera-
ture, skin reddening, protein extravasation, oedema, and augmented nociceptive stimulation,
whereas maladaptive cortical reorganization contributes to experienced pain and motor dys-
function [2]. The degree of cortical reorganization is found to be directly related to intensity of
pain [3].
The role of psychological factors has also been considered, both in the development of
CRPS-1 and in its progression [4]. It has been shown that, in chronic musculoskeletal pain, pa-
tients’ beliefs about their pain are a disabling factor, and that pain-related fear and associated
avoidance behaviours contribute to the development of chronic pain-related disability [5]. Sim-
ilar associations are suggested for patients with CRPS-1 [6].
One of the models that could explain the associations between fear and CRPS-1 is the fear-
avoidance model (Fig 1) [7]. According to this model, pain-related fear influences the develop-
ment and maintenance of pain-related disability [8]. Pain may lead to catastrophic thoughts,
which lead to fear and avoidance of movements. In turn, this avoidance leads to disability and
increase of pain [9].
In a meta-analysis about pain-related fear and disability in patients with acute and chronic
pain, Zale et al. concluded that pain-related fear might be an important target for treatments
intended to reduce pain-related disability [10]. Looking at the fear-avoidance model, it could
be expected that interfering with the vicious circle by reducing catastrophic thoughts and fear
of pain would decrease disability and pain, as is shown with graded exposure therapy (GEXP)
[11]. GEXP is based on the fear-avoidance model and, using a graded hierarchy of fear-eliciting
situations, it modifies the meaning patients attach to their pain. Reduction of catastrophic
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thoughts and fear of pain with graded fear exposure is associated with regaining functional
abilities in patients with CRPS-1 [8,11,12].
According to the principles of the fear-avoidance model, pain catastrophizing and pain-re-
lated fear have to be treated first, in order to restore functional abilities (Fig 1). However, it
may be possible that a more functionally directed approach, with the focus on increased motor
activity and normal use of the affected limb in daily life, could also lead to improved patient
outcomes. Ten years ago, the practices of a Macedonian woman, Ms Shinka, caught the atten-
tion of two Dutch physicians. She literally ignored the patients’ expressions of pain and their
fear of someone touching their affected limb, and started moving it passively. With a remark-
able result: she appeared to be able to considerably decrease pain and improve function in pa-
tients with treatment-resistant CRPS-1. [13]. As a derivative of her treatment, Pain Exposure
Physical Therapy (PEPT) was developed, in which therapists no longer focus their attention on
pain or fear, but rather on physical activities and function [14,15].
Fig 1. The fear-avoidancemodel, showing the targets of Pain Exposure Physical Therapy and graded exposure treatment. In this model, pain
catastrophizing, pain-related fear and avoidance are thought to be mediators for the treatment of disability and consequently pain. Reproduced from Vlaeyen
and Linton [7]. PEPT = Pain Exposure Physical Therapy. GEXP = Graded Exposure treatment.
doi:10.1371/journal.pone.0123008.g001
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PEPT is a patient-centred physical therapy, tailored towards improving activities in daily
life, using progressive-loading exercises, desensitization and “self-forced” use, in which patients
have to encourage themselves to use their affected extremity, both during treatment exercises
and in daily activities, without the use of medication. Whereas graded exposure therapy focuses
on fear, PEPT puts disuse at the centre. It takes patients to their physiological boundaries to re-
gain normal functional abilities. Ek et al. studied PEPT in a cohort of 106 adult patients with
long-lasting CRPS-1. Function improved in 90% of patients, and full functional recovery was
observed in 46% of patients [14]. In a multiple single-case study on patients with CRPS-1, Van
de Meent et al. demonstrated the safety and possible effectiveness of PEPT [15].
In Dutch clinical practice, clinicians usually treat patients with CRPS-1 with conventional
therapy, following the national guideline, which is based on systematic reviews of the available
studies at the time of conception [16]. The guideline includes pharmacological interventions
with various drugs to decrease pain, and intensive pain-contingent physical therapy. Conven-
tional treatment is mainly focused at decreasing pain, where pain is regarded as a sign of physi-
cal overload. By decreasing pain with (usually) pharmacological interventions, the physical
capacity is increased with pain-contingent physical therapy.
Recently, we performed a randomized controlled trial (RCT), comparing the effectiveness
of PEPT and conventional treatment in patients with CRPS-1, the PEPTOC trial (Pain Expo-
sure Physical Therapy Or Conventional; paper submitted). The primary analysis showed that
only the active range of motion improved significantly more after PEPT than after convention-
al treatment. Further per protocol analysis, however, showed an additional larger reduction of
disability and pain in patients treated with PEPT than patients treated conventionally.
Following the results of the multiple single-case study [15] and the PEPTOC trial, we hy-
pothesized that reducing fear is not a prerequisite for reducing disability and pain in patients
with CRPS-1, and that treatment does not primarily need to focus on reduction of fear or pain
to be effective. To explore the working mechanism of PEPT in more detail, we investigated
whether pain-related fears were mediators of the effect of Pain Exposure Physical Therapy on
disability and pain in patients with CRPS-1.
Methods
Design
The PEPTOC trial was designed as a randomized controlled trial with blinding of the assessor.
We collected data at baseline and after three, six, and nine months follow-up [17]. The primary
results of the trial will be published elsewhere. The current study is an explorative mediation
analysis of the PEPTOC trial.
Participants
Inclusion criteria for the PEPTOC trial were 1) positive scoring on the research diagnostic cri-
teria for CRPS as proposed by Harden et al. (shown below) [18], 2) age between 18 and 80
years, and 3) first assessment between 3 and 24 months after the inciting event. Criteria for ex-
clusion were 1) CRPS-1 in more than one extremity, 2) relapse of CRPS-1, 3) pregnancy or lac-
tation, and 4) prior sympathectomy of the affected limb.
Diagnostic CRPS criteria [18]
1. Continuing pain, which is disproportionate to any inciting event;
2. At least one symptom in each of the four following categories;
Sensory: reports of hyperalgesia and/or allodynia
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Vasomotor: reports of temperature asymmetry, skin color changes and/or skin
color asymmetry
Sudomotor/edema: reports of edema, sweating changes and/or sweating asymmetry
Motor/trophic: reports of decreased range of motion, motor dysfunction and/or
trophic changes
3. At least one sign in two or more of the following categories:
Sensory: evidence of hyperalgesia and/or allodynia
Vasomotor: evidence of temperature asymmetry (>1°C), skin color changes and/or skin
color asymmetry
Sudomotor/edema: evidence of edema, sweating changes and/or sweating asymmetry
Motor/trophic: evidence of decreased range of motion, motor dysfunction and/or
trophic changes
4. There is no other diagnosis that better explains the signs and symptoms.
Interventions
After baseline measurements, patients received either the experimental treatment Pain Expo-
sure Physical Therapy (PEPT) or the conventional control treatment (CONV).
Experimental treatment. At the start of treatment with PEPT all medication aimed at
CRPS-1, including analgesics, was stopped, as use of medication is not part of the treatment.
PEPT was conducted by two physical therapists together. Patients received thorough education
about their condition, the working mechanism of pain (acute versus chronic, central pain sen-
sation and memory) and pain-related avoidance behaviour, and the rationale and content of
PEPT. Therapists explained that pain is not a sign of injury, but rather a “false warning sign”:
pain does hurt, but does not mean harm.
Therapists explained that they acknowledge that the patients might temporarily experience
pain, but ignored further expressions of pain and taught the patients and their spouses to do
the same. The therapists explained that because of improved function, the pain would eventual-
ly diminish [14,15,17].
After thorough instruction about PEPT, the patients, along with their spouses, set their per-
sonal, functional treatment goals. The therapists acted mainly as instructors and coaches, and
confirmed and rewarded progression with positive feedback.
The therapists confidently touched the affected limb and passively moved it beyond the ac-
tive range of motion. They then stimulated the patients and their spouses to do the same. They
convinced the patients that moving and touching the affected limb is safe.
Further treatment consisted of progressive-loading exercises, focused on specific daily activ-
ities and quality of movement, and other regular physical therapy techniques, like muscle
strength training and joint mobility exercises. Patients learned how to decrease their skin sensi-
tivity for touch and pressure by performing self-massage and “self-forced” use of the affected
extremity during exercises and in daily activities. Patients had to perform the exercises at home
and incorporate them in their daily life, whereas their spouses had to ensure that the exercises
were performed correctly. Spouses were instructed to ignore the patients’ pain behaviour and
change their protective role into a motivating and coaching one.
Pain Exposure Physical Therapy and Fear in Patients with CRPS-1
PLOS ONE | DOI:10.1371/journal.pone.0123008 April 28, 2015 5 / 16
PEPT consists of a maximum of five treatment sessions and is time-contingent, in contrast
to the usual pain-contingent physical therapy. The content and the number of treatment ses-
sions are not influenced by experienced pain. More details on Pain Exposure Physical Therapy
have been reported elsewhere [14,15,17].
Control treatment. Conventional treatment (CONV) was based on the current Dutch na-
tional guideline and included pharmacological interventions combined with physical therapy
in a pain-contingent manner [16]. The recommendations in this guideline result from a large
multidisciplinary consensus meeting and systematic reviews available at the time of conception
in 2006. Conventional physical therapy was focused on controlling pain, using movements
within pain limits, mild exposure and increasing the capacity to perform daily activities step by
step in a pain-contingent manner. Pharmacological treatment included the use of analgesics in
a step-up procedure in accordance with the WHO pain ladder; free radical scavengers includ-
ing dimethylsulphoxide 50% ointment (DMSO) and N-acetylcysteine; calcium channel block-
ers; and ketanserine. Patients presenting with allodynia or hyperalgesia were given gabapentin,
amitriptyline, or carbamazepine. Dystonia, myoclonia, and muscle spasms were treated with
baclofen, diazepam, or clonazepam. In the case of cold skin, the anaesthesiologist would pre-
scribe vasodilating drugs such as verapamil, ketensin, and pentoxiphylline. In case of insuffi-
cient clinical effect, sympathetic blockade, transcutaneous electrical nerve stimulation, or
spinal cord stimulation was considered [16].
Outcome measures
The outcomes of interest for the mediation analysis were pain-related disability, pain, fear-
avoidance beliefs, pain catastrophizing, and fear of movement and (re)injury (kinesiophobia).
Pain-related disability was measured with the Pain Disability Index (PDI), a 7-item ques-
tionnaire with a range of 0–70 points that assesses to what extent daily activities are disrupted
by pain. The questions comprise aspects of family and home responsibilities, recreation, social
activity, occupation, sexual behaviour, self care, and life-support activities. We used a Dutch
language version, which has proven to be valid and reliable in patients with musculoskeletal
pain [19].
We measured pain on a visual analogue scale (VAS-pain), a widely used, reliable and valid
tool for the assessment of pain [20]. A score of 1 equals “no pain”, whereas 10 means “worst
imaginable pain”.
The Fear-Avoidance Beliefs Questionnaire (FABQ) measures patients’ beliefs about how
their pain influences work and physical activities [21,22]. The 16-item questionnaire has good
psychometric properties [23] and the scores range from 0–42 points for the work subscale and
from 0–24 for the physical activities subscale. We used the Dutch language version as translat-
ed by Vendrig et al. [22].
For measuring pain catastrophizing, we used the Dutch language Pain Catastrophizing
Scale (PCS), a 13-item questionnaire with questions about the three aspects of catastrophizing:
rumination, magnification and helplessness [24]. The PCS is one of the most widely used in-
struments for measuring catastrophic thinking related to pain and has good psychometric
properties [25,26]. The PCS ranges from 0–52 points, with its subscales rumination, magnifica-
tion and helplessness ranging from 0–16, 0–12, and 0–24 respectively.
We measured fear of movement and (re)injury using the Tampa Scale for Kinesiophobia-11
(TSK-11) [27], a brief, reliable and valid measure [28], with a score ranging from 11–44 points.
We used the Dutch language version as translated by Vlaeyen et al.
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Data analysis
Because of the exploratory nature of this particular study, we did not abide to the randomiza-
tion protocol and analysed all patients according to the treatment they received from the begin-
ning of the trial.
We used descriptive analyses to describe patient characteristics. Fig 2 shows the model we
used to analyse potential mediation between the independent variable treatment (PEPT or con-
ventional treatment), the mediators (fear-avoidance beliefs, pain catastrophizing, or kinesio-
phobia), and the dependent variables (pain-related disability or pain).
According to the steps described by Baron and Kenny [29], we planned to perform three
analyses, using linear mixed models. First, we estimated the total effect of treatment (indepen-
dent variable) on the dependent variables pain-related disability or pain (Fig 2, arrow c). Sec-
ond, we estimated the effect of treatment on the potential mediators (Fig 2, arrow a). Only if
both effects (between-group differences) were statistically significant, using alpha levels of up
to 0.10 due to the exploratory nature of this study, we performed the third analysis, in which
we regressed the dependent variables on both the mediators and the independent variable. For
mediation to be present, the mediator had to be significantly related to the outcome (path b)
and the direct effect of the independent variable on the outcome (arrow c1) had to be smaller
than the total effect (arrow c) [30]. On the basis of the standardised coefficients, we also
planned to assess the proportion of mediated effect: (c—c1)/c x 100% [30].
We used linear mixed models with unstructured repeated covariance, treatment and mea-
surement in time as factors and outcome at baseline as covariate, to determine the between-
group differences on the dependent variables over time. Because 26.8% of the patients switched
groups prior to treatment initiation, shifts in baseline characteristics occurred. Therefore, we
added these as potential confounders (affected extremity and dominant side affected as factors,
and time since inciting event as covariate) to the analysis. If they affected the between-group es-
timates by more than 10%, we considered them as confounders and added them to the models
Fig 2. Model for the mediation analysis. This model was used to analyse potential mediation between the independent variable (Pain Exposure Physical
Therapy versus conventional treatment), the mediator variable (fear-avoidance beliefs or pain catastrophizing or kinesiophobia), and the dependent variable
(pain-related disability or pain) [30]. PEPT = Pain Exposure Physical Therapy. CONV = conventional treatment.
doi:10.1371/journal.pone.0123008.g002
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[31]. Linear mixed models deal with missing data by predicting the best-fitting line for each pa-
tient without data imputation. We performed the analyses with SPSS 20.0.
Ethics statement
The Ethics Committee on Research Involving Human Subjects of Arnhem and Nijmegen, The
Netherlands (CMO Regio Arnhem-Nijmegen), approved this study. The study is registered at
www.clinicaltrials.gov, NCT00817128, and at www.trialregister.nl, NTR 2090.
All participants provided both oral and written informed consent prior to data collection.
Results
Participants
Between January 2009 and June 2011, 56 patients were included in the PEPTOC trial. Thirty-
five patients received Pain Exposure Physical Therapy and 21 patients received conventional
treatment. Table 1 shows the baseline characteristics according to the treatment they received.
At first glance, the CONV group contained relatively more patients with an affected upper ex-
tremity and the dominant side was relatively more often affected in this group. Also, the mean
time since inciting event and the dispersion appeared different between groups. Although the
differences in baseline characteristics were not significant between groups, the variables “affect-
ed extremity”, “dominant side affected”, and “time since inciting event” did alter the between-
group estimates by more than 10% and we therefore added them as confounders to the linear
mixed models [31].
Disability and pain (step 1)
Disability and pain improved significantly in both groups, as is shown in Fig 3 and Table 2.
Disability decreased with 69% (mean improvement 23.9; 95% CI 18.7 to 29.1), and there was a
pain reduction of 57% (mean improvement 2.9; 95% CI 1.9 to 3.9) for the patients in the PEPT
group. In the CONV group, disability decreased with 37% (mean improvement 16.0; 95%
CI 8.0 to 24.1), and pain decreased with 23% (mean improvement 1.4; 95% CI 0.4 to 2.5).
The analysis showed a significant total effect of PEPT on disability, with an estimated mean
between-group difference of 7.8 points (95% CI 1.1–14.5; p = 0.02) in favour of PEPT. Pain im-
proved on average 1.8 points more in the PEPT group than in de CONV group (95% CI 0.4–
3.2; p = 0.01) (Table 3) after adjusting for confounding.
Table 1. Baseline characteristics of the participants.
Baseline characteristics Overall (n = 56) PEPT (n = 35) CONV (n = 21)
Gender (female) 45 (80.4%) 29 (82.9%) 16 (76.2%)
Age (years)* 44.3 (16.6) 43.1 (16.9) 46.2 (16.5)
Affected extremity (upper) 37 (66.1%) 20 (57.1%) 17 (81.0%)
Dominant side affected 32 (57.1%) 17 (48.6%) 15 (71.4%)
Time since event (months)† 6.0 (4.0–9.0) 6.0 (4.0–8.0) 6.0 (5.0–10.5)
* Mean (SD).
† Median (interquartile range).
PEPT = Pain Exposure Physical Therapy. CONV = conventional treatment.
doi:10.1371/journal.pone.0123008.t001
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Fig 3. Outcomes for both treatment groups at baseline and at 3, 6, and 9 months follow-up. Panel A: dependent variables pain-related disability and
pain. Panel B: potential mediators fear-avoidance beliefs, pain catastrophizing, and kinesiophobia. PDI = Pain Disability Index. VAS = Visual Analogue
Scale. FABQ = Fear-Avoidance Beliefs Questionnaire. PCS = Pain Catastrophizing Scale. TSK = Tampa Scale for Kinesiophobia. CONV = conventional
treatment. PEPT = Pain Exposure Physical Therapy.
doi:10.1371/journal.pone.0123008.g003
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Fear-avoidance beliefs, catastrophizing, and kinesiophobia (step 2)
Fear-avoidance beliefs, catastrophizing, and kinesiophobia decreased significantly in both
groups (Fig 3, Table 2). In the PEPT group, the score on the FABQ work and FABQ physical
activities decreased with 46% (mean improvement 8.7; 95% CI 4.3 to 13.2) and 49% (mean im-
provement 5.1; 95% CI 2.4 to 18.6) respectively, pain catastrophizing decreased with 64%
(mean improvement 13.8; 95% CI 8.9 to 18.6), and kinesiophobia with 56% (mean improve-
ment 5.7; 95% CI 3.4 to 8.0). Patients in the CONV group experienced a decrease in the FABQ
work and physical activities scores of 37% (mean improvement 6.0; 95% CI -2.2 to 14.3; n.s.)
and 27% (mean improvement 5.6; 95% CI 0.3 to 10.9) respectively. Pain catastrophizing de-
creased with 40% (mean improvement 12.8; 95% CI 7.8 to 17.3) and kinesiophobia with 39%
(mean improvement 6.1; 95% CI 2.8 to 9.4). However, significant between-group differences
were found for neither the three potential mediators, nor their subscales, using alpha levels of
0.05 and 0.10 (Table 3).
Table 2. Descriptives of the dependent variables and the mediator variables.
Dependent variable Baseline 3 months 6 months 9 months
Pain Disability Index (0–70)
PEPT (n = 33) 33.91 (13.00) 19.87 (13.56) 12.48 (11.96) 10.40 (9.54)
CONV (n = 19) 37.17 (13.06) 28.18 (16.38) 22.58 (16.23) 23.48 (18.81)
VAS-pain (1–10)
PEPT (n = 35) 6.23 (2.40) 3.97 (2.47) 3.90 (2.62) 3.24 (2.31)
CONV (n = 21) 7.33 (1.96) 6.24 (3.21) 5.65 (3.42) 5.89 (3.16)
Mediator variable Baseline 3 months 6 months 9 months
FABQ work (0–42)
PEPT (n = 32) 19.32 (11.72) 13.38 (11.29) 10.92 (10.38) 10.38 (11.65)
CONV (n = 18) 23.14 (13.18) 17.26 (12.86) 15.65 (13.90) 14.51 (13.94)
FABQ physical activity (0–24)
PEPT (n = 33) 11.36 (5.88) 8.67 (5.31) 6.70 (5.05) 5.82 (4.85)
CONV (n = 18) 14.67 (4.70) 13.00 (5.24) 9.88 (6.95) 10.75 (6.86)
Pain Catastrophizing Scale overall (0–52)
PEPT (n = 32) 22.81 (11.65) 12.70 (10.31) 9.00 (10.32) 8.24 (10.29)
CONV (n = 18) 24.91 (14.83) 17.00 (16.67) 15.30 (13.81) 14.94 (15.00)
PCS rumination (0–16)
PEPT (n = 32) 8.36 (3.90) 5.52 (3.98) 4.07 (4.25) 3.59 (4.03)
CONV (n = 18) 9.28 (4.76) 5.88 (5.43) 5.78 (5.22) 5.41 (5.10)
PCS magniﬁcation (0–12)
PEPT (n = 32) 3.28 (2.77) 1.88 (2.56) 0.90 (1.69) 0.86 (2.01)
CONV (n = 18) 3.61 (3.52) 2.50 (3.45) 1.44 (1.95) 1.65 (2.78)
PCS helplessness (0–24)
PEPT (n = 32) 11.19 (6.06) 5.34 (4.94) 4.03 (5.20) 3.79 (5.12)
CONV (n = 18) 11.99 (7.75) 8.58 (8.03) 8.16 (7.81) 7.88 (8.12)
Tampa Scale for Kinesiophobia (11–44)
PEPT (n = 32) 22.00 (6.37) 18.53 (7.03) 16.38 (5.59) 15.79 (5.07)
CONV (n = 19) 24.39 (6.42) 20.03 (6.10) 19.13 (7.02) 19.11 (8.12)
All data are mean (SD).
PEPT = Pain Exposure Physical Therapy. CONV = conventional treatment. VAS = Visual Analogue Scale. FABQ = Fear-Avoidance Beliefs
Questionnaire. PCS = Pain Catastrophizing Scale.
doi:10.1371/journal.pone.0123008.t002
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Mediation (step 3)
Because there were no significant effects of treatment on pain-related fears, we did not perform
step 3 of the mediation analysis, nor could we assess the proportion of the mediated effect.
Discussion
Statement of principal findings
With this exploratory study on the working mechanism of Pain Exposure Physical Therapy, we
found that in this population the effect of PEPT, compared to conventional treatment, on dis-
ability and pain was not mediated by pain-related fears. We also found that in both treatment
groups pain-related fears improved significantly without primarily focusing at fear reduction.
According to this study however, reduction of fear does not explain the working mechanism of
PEPT beyond conventional treatment.
Meaning of the study
In contrast to standard physical therapy and other conventional treatment modalities [16],
PEPT does not primarily focus on reducing pain, but on reducing disability and improving
motor activities. PEPT is based on the supposition that limited use or even non-use of an ex-
tremity, whether or not caused by fear of movement or pain, can lead to disease deterioration
[9]. Patients’ behaviour towards pain can be an important aspect in experienced physical im-
pairments [32]. PEPT interferes with disuse or non-use by directly stimulating motor
activities and unrestricted use of the affected extremity in daily life. By forcing the extremity to
take part in daily activities, it becomes part of the functioning body and the formerly disrupted
body schema.
In patients with CRPS-1, shrinkage of the cortical representation of the affected extremity in
the primary somatosensory cortex has been observed [33]. There is a miscommunication be-
tween the brain and the extremity and the degree of cortical reorganisation is directly related to
pain intensity [3]. Cortical reorganisation can be modified by behavioural interventions that
provide correct feedback to the brain [34] and restore the communication. Analgesics and
other types of treatment that could interfere with this communication should be avoided.
Table 3. Mediation analysis with estimated group differences based on linear mixedmodels*.
Dependent variable Independent variable Estimated group difference (95% CI) p-value
Path c Pain Disability Index PEPT vs. CONV 7.77 (1.09 to 14.45) 0.02
VAS-pain PEPT vs. CONV 1.83 (0.44 to 3.23) 0.01
Path a FABQ work PEPT vs. CONV 2.27 (-2.47 to 7.02) 0.34
FABQ physical activity PEPT vs. CONV 2.29 (-0.78 to 5.35) 0.14
Pain Catastrophizing Scale overall PEPT vs. CONV 1.72 (-3.31 to 6.75) 0.44
PCS rumination PEPT vs. CONV 0.03 (-2.04 to 2.10) 0.92
PCS magniﬁcation PEPT vs. CONV 0.00 (-0.88 to 0.89) 0.97
PCS helplessness PEPT vs. CONV 1.67 (-1.09 to 4.43) 0.17
Tampa Scale for Kinesiophobia PEPT vs. CONV 1.01 (-1.74 to 3.76) 0.68
*Linear mixed models with unstructured repeated covariance, treatment and measurement in time as factors and outcome at baseline as covariate,
corrected for “extremity”, “dominant side affected”, and “time since inciting event” as confounding variables.
PEPT = Pain Exposure Physical Therapy. CONV = conventional treatment. VAS = Visual Analogue Scale. FABQ = Fear-Avoidance Beliefs
Questionnaire. PCS = Pain Catastrophizing Scale.
doi:10.1371/journal.pone.0123008.t003
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Therefore, all medication aimed at CRPS-1 are stopped prior to treatment with PEPT. Maihof-
ner et al. showed that cortical reorganisation can be reversed after effective treatment of CRPS-
1 [35]. Performing normal activities and realizing this can be done without harm can be a trig-
ger for cortical re-reorganisation, which consequently can lead to a decrease of pain [3].
Involving spouses in the treatment of CRPS-1 is an important component of the treatment.
Not only should spouses know what patients are dealing with and should they ensure that the
patients perform their exercises and support them, it is important that spouses ignore patients’
expressions of pain. It is demonstrated that spouses who reinforce pain can cause a 2.5-fold in-
crease in patients’ brain response to pain, measured with electroencephalographic potentials,
compared to spouses who ignore pain or punish the patients for expressing pain [34].
Our exploratory study showed that patients with CRPS-1 can be effectively treated, even
though treatment is not primarily focused on reduction of pain or fear. However, since we
found no between-group difference in reduction of fear, we cannot conclude that this treat-
ment effect was caused by a reduction in pain-related fears.
A number of reasons can be identified for why we did not find a difference in decrease of
fear between PEPT and CONV. The most obvious reason is that there is no difference in fear
reduction between the two treatments. It is possible that both treatments reduce fear in their
own way. With conventional treatment, there is definitely some attention for the fear patients
experience; patients do not have to cross their own “boundaries”. Reinforcement of success ex-
periences is used to show that the patients do not have to fear movement nor pain. PEPT, on
the other hand, enhances the patients’ self-efficacy and stresses the patients to ignore their pain
and use their affected limb despite possibly eliciting pain. As a result of their success experi-
ences, this could explain a reduction of fear in patients treated with PEPT. In both cases, reduc-
tion of fear could be related to the experience that no harm is done. Apart from an effect of
treatment, the reduction of fear in both groups could be due to a favourable natural course
[36]. When pain is reduced, either following treatment or naturally, fear can be reduced even
further. Paying attention to the patient and their condition may be beneficial, as is regaining
confidence in a positive outcome.
In the multiple single-case study by Van de Meent et al., using a similar cohort, there was
however no reduction in kinesiophobia during a baseline period of three months prior to treat-
ment initiation [15]. This suggests that the improvement in pain-related fears we found in both
groups resulted from treatment rather than a natural course.
Strengths and weaknesses of the study
We did not abide to the randomization protocol. Because with this particular study we wanted
to explore the working mechanism of PEPT, we looked at the sole effects of both treatments.
Therefore, we analysed the patients according to the treatment they received from the begin-
ning of the trial, while adjusting for confounding. The sample size calculation of the trial was
consequently based on detecting differences in clinical effectiveness between the two interven-
tions, rather than on mediation effects. As a consequence, the sample size may not have been
adequate to identify mediation effects, which may have led to a type II error. To reduce the
chance of a type II error and because of the exploratory nature of this study, we also interpreted
the results of the analysis using an alpha of 0.10. However, this did not change our conclusion.
One of the inclusion criteria was first assessment between 3 and 24 months after the inciting
event, yet the median duration of complaints for the participants in this study was rather short
(6 months). Only 12.5% of the patients reported at our outpatient clinic12 months after the
inciting event. This reduces the generalizability of our results to a population with more
chronic patients.
Pain Exposure Physical Therapy and Fear in Patients with CRPS-1
PLOS ONE | DOI:10.1371/journal.pone.0123008 April 28, 2015 12 / 16
During the screening process, we did not systematically check for psychological or psychiat-
ric comorbidities by means of questionnaires or psychological evaluation. Possible differences
could add some explanation to our data. However, we did perform a thorough history taking in
all patients during screening, which did not reveal the presence of such comorbidities.
Throughout the trial, a psychologist was available in case there were concerns about the psy-
chological condition of patients.
Because this is the first study that explored possible mediation of pain-related fears in treat-
ing patients with CRPS-1 with PEPT, there are no other studies to compare our results with.
However, there are several trials on treatment modalities focusing on reduction of fear in pa-
tients with CRPS-1. One of these trials (De Jong et al. [11]) studied graded exposure therapy
(GEXP), a form of cognitive behavioural treatment that is aimed at reducing pain-related fears.
In approximately 20 treatment sessions, performed by a behavioural therapist and a rehabilita-
tion specialist, patients were gradually exposed to situations they had identified as dangerous
or threatening. De Jong et al. included only females (n = 8), with a mean duration of com-
plaints of 3.0 years (at least 6 months) and patients had to report substantial kinesiophobia
(TSK>39 on the 17-item questionnaire; corresponding to TSK>25 on the 11-item question-
naire) at baseline. The results of this single-case experimental trial showed that GEXP was suc-
cessful in decreasing pain-related fear, pain intensity, and disability in female patients [11].
Although we cannot compare the results of both trials, because we included patients with a
relatively short history, disregarding their levels of fear, we can state that it appears that in an
average population with a relatively short duration of complaints, CRPS-1 can be effectively
treated, without primarily focusing on fear, thus avoiding long and costly treatment. After
thorough education that pain is not a sign of injury and moving is not harmful but rather pro-
motes quick improvement, it is possible to reduce disability and pain in a safe and
effective manner.
Because, in contrast to PEPT, GEXP applies graded exposure, the duration of treatment is
longer (10 to 20 sessions with GEXP [8,11], compared to a maximum of 5 treatment sessions
with PEPT [17]), probably making it more costly than PEPT.
Unanswered questions and future research
It should be emphasized that our study findings need to be replicated in other, preferably larg-
er, studies to elucidate the potential role of pain-related fears as mediators of the effects of
PEPT on pain and disability.
Furthermore, it would be interesting to systematically compare graded exposure therapy
and Pain Exposure Physical Therapy and see which of the two treatment modalities is more ef-
fective and whether patient characteristics, such as disease duration and levels of fear, influence
their effectiveness.
In our trial, patients did not report excessive levels of pain-related fears, compared to other
patients with CRPS-1 (mean TSK = 24 [9]), soft tissue injury (mean PCS = 28 [37]), low back
pain (FABQ work>34 [38], FABQ physical activity>14 [39], TSK>24[27], mean TSK = 43
[40]), or fibromyalgia (mean TSK = 37 [40]). It could be possible that patients with too much
fear or chronic complaints do not benefit from PEPT because they lack internal motivation or
feelings of self-efficacy. PEPT might even provoke fear in these patients, preventing them from
committing to the treatment. Graded exposure might be a better approach for such patients.
In conclusion, our analysis showed that there was no indication that reduction of disability
and pain by PEPT, in comparison to conventional treatment, was mediated by pain-related
fears, regardless of whether the reduction of fear was caused by treatment or by any other
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factor. Hence, this seems to indicate that pain-related fears do not have to be treated specifically
in order to reduce disability and pain effectively in patients with CRPS-1.
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